Teaming up with the NBA

In June 2020, we formed a collaboration with the National Basketball Association (NBA) and the Players Association (NBPA) to develop a new saliva-based SARS-CoV-2 test (SalivaDirect) and to uncover key aspects of viral replication and transmission. Here is a selection of some of the news articles:
YSPH Magazine: YSPH-NBA Partnership Key to Success of New COVID-19 Saliva Test
The Athletic: How an assist from the NBA set up a small Yale lab for a COVID breakthrough
ESPN: Saliva-based coronavirus test funded by NBA, NBPA gets emergency authorization from FDA
Yale Daily News: Automation, pooling could come next for SalivaDirect as research team juggles authorization requests, media attention
Wall Street Journal: The FDA Authorizes a Cheap, Fast Saliva Test—and the NBA Is Involved
USA Today: How NBA has expanded community testing for COVID-19 in team markets
Yale News: Yale and NBA partner to study efficacy of new COVID-19 test